Live Breaking News & Updates on Fate Therapeutics Inc

Stay updated with breaking news from Fate therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Fate Therapeutics, Inc. (NASDAQ:FATE) Shares Sold by Bruce & Co. Inc.

Bruce & Co. Inc. lowered its stake in Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) by 28.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 143,000 shares of the biopharmaceutical company’s stock after selling 57,000 shares during the period. Bruce & […] ....

United States , Piper Sandler , Mitsubishi Ufj , Exchange Commission , Epiq Partners , Bruce Co , Fate Therapeutics Inc , Morgan Stanley , Victory Capital Management Inc , Kokusai Asset Management Co , Fate Therapeutics , Free Report , Capital Management , Asset Management , Get Free Report , Visit Holdingschannel , Fate Therapeutics Daily ,

Bruce & Co. Inc. Sells 57,000 Shares of Fate Therapeutics, Inc. (NASDAQ:FATE)

Bruce & Co. Inc. trimmed its stake in shares of Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) by 28.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 143,000 shares of the biopharmaceutical company’s stock after selling 57,000 shares during the quarter. Bruce & […] ....

United States , Exchange Commission , Bruce Co , Epiq Partners , Fate Therapeutics Company Profile , Fate Therapeutics Inc , Vanguard Personalized Indexing Management , Victory Capital Management Inc , Fate Therapeutics , Free Report , Capital Management , Get Free Report , Visit Holdingschannel , Fate Therapeutics Daily ,

Sana Biotechnology (NASDAQ:SANA) and Fate Therapeutics (NASDAQ:FATE) Critical Comparison

Sana Biotechnology (NASDAQ:SANA – Get Free Report) and Fate Therapeutics (NASDAQ:FATE – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, risk, profitability and valuation. Volatility & Risk Sana Biotechnology has a […] ....

United States , San Diego , Fd Therapeutics Inc , Sana Biotechnology Inc , Beam Therapeutics Inc , Ono Pharmaceutical Co , Fate Therapeutics Inc , Harvard College , Sana Biotechnology , Get Free Report , Fate Therapeutics , Given Fate Therapeutic , Fate Therapeutic , Beam Therapeutics , Ono Pharmaceutical , Sana Biotechnology Daily ,

Brokerages Set Fate Therapeutics, Inc. (NASDAQ:FATE) Price Target at $6.58

Brokerages Set Fate Therapeutics, Inc. (NASDAQ:FATE) Price Target at $6.58
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United States , Piper Sandler , Epiq Partners , Victory Capital Management Inc , Canaccord Genuity Group , Vanguard Personalized Indexing Management , Fate Therapeutics Inc , Morgan Stanley , Fate Therapeutics , Get Free Report , Marketbeat Ratings , Genuity Group , Personalized Indexing Management , Victory Capital Management , Capital Management , Get Free , Fate Therapeutics Daily ,

Certain Pre-Funded Warrants of Fate Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 19-MAY-2024.

Certain Pre-Funded Warrants of Fate Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 19-MAY-2024. These Pre-Funded Warrants will be under lockup for 61 days starting from 19-MAR-2024 to. ....

Fate Therapeutics Inc , Certain Pre Funded Warrants , Fate Therapeutics , Lock Up Agreement Ending , Pre Funded Warrants ,